MCI Onehealth Technologies, Inc. Class A (TSE:AIDX) has released an update.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
HEALWELL AI is set to enhance its clinical research capabilities through the strategic acquisition of BioPharma Services Inc., a prominent Canadian Contract Research Organization (CRO) specializing in bioequivalence and early-stage clinical trials. By integrating BioPharma’s expertise with its own AI technologies and vast patient databases, HEALWELL aims to accelerate and improve patient-centered clinical research. The deal includes an initial $11.9 million in cash and shares with potential additional performance-based payments, bolstering HEALWELL’s projected annual revenue to over $65 million.
For further insights into TSE:AIDX stock, check out TipRanks’ Stock Analysis page.